TUESDAY, June 7, 2022 (HealthDay News) — Reacting to the nation’s opioid epidemic, doctors in the United States are co-prescribing fewer opioid painkillers and benzodiazepines such as Ativan and Xanax, federal health officials report. When these drugs are taken together, the odds of an overdose, even a fatal overdose, increaseContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Patients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease. Now, a new investigation may have landed on a surprising solution — a dummy pill that contains noContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be asContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Here’s a simple weapon to employ against the opioid epidemic: New research finds that placing time limits on prescriptions for highly addictive narcotic painkillers may reduce the risk of misuse. In 2019, 1% of opioid prescriptions from U.S. dentists and surgeons were filledContinue Reading
FRIDAY, June 3, 2022 (HealthDay News) — A growing number of U.S. kids are attempting suicide by medication overdose — with the biggest increase seen among preteens, a recent study shows. Researchers found that between 2015 and 2020, there was a 27% increase in overdose suicide or attempted suicide amongContinue Reading
FRIDAY, June 3, 2022 (HealthDay News) — Children under the age of 5 may be able to get their first COVID vaccinations as early as June 21, the White House said Thursday. An advisory panel to the U.S. Food and Drug Administration will meet on June 14-15 to weigh theContinue Reading
FRIDAY, June 3, 2022 (HealthDay News) — Adults who get COVID-19 could have antibodies circulating in their blood for nearly 500 days after infection, new research suggests. “We now have a good estimate of how long antibodies last after a COVID-19 infection,” said study author Michael Swartz, an associate professorContinue Reading
FRIDAY, June 3, 2022 (HealthDay News) — Vaccination played a crucial role when Americans were deciding whether to have surgery during the pandemic, a new study finds. “It’s critical to understand what factors affect a patient’s decision to have surgery during an infectious pandemic if we want to help reduceContinue Reading
THURSDAY, June 2, 2022 (HealthDay News) — Pfizer Inc. said Wednesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine in children under the age of 5. The company said in a statement that it has provided the agency withContinue Reading
THURSDAY, June 2, 2022 (HealthDay News) — The number of COVID-19 vaccine doses received — not the combinations — is the key to strengthening your immune system to protect against different variants of the coronavirus, including Omicron, a new study suggests. A team from the Chinese University of Hong KongContinue Reading
THURSDAY, June 2, 2022 (HealthDay News) — Children who have had COVID-19 aren’t protected against the Omicron variant, but vaccination does cut their chances of infection, a new study shows. “I hear parents say, ‘Oh, my kid had COVID last year,’” said senior study co-author Dr. Adrienne Randolph, from BostonContinue Reading
TUESDAY, May 24, 2022 (HealthDay News) — COVID-19 can make a comeback after an infected person has gone through a round of Paxlovid, the antiviral used to minimize a bout with the coronavirus, according to an advisory issued Tuesday by the U.S. Centers for Disease Control and Prevention. “Recent caseContinue Reading
TUESDAY, May 24, 2022 (HealthDay News) — Cancer patients continue to face more risk from COVID-19, even if they’ve been vaccinated. Although vaccination is effective for most people who have cancer (even though they’re immunocompromised by the disease and their cancer treatments), its effectiveness wanes more rapidly in this group,Continue Reading
MONDAY, May 23, 2022 (HealthDay News) — Pfizer/BioNTech says a three-dose regimen of its COVID-19 vaccine appears to provoke a strong immune response in the youngest age group of children — those aged 6 months to 5 years. This is the only age group not yet approved for COVID-19 vaccinationContinue Reading